Vinati Organics Managing Director and CEO Vinati Saraf Mutreja provided a general business update during an interview with CNBC-TV18 on September 29, 2026. The session offered insights into the company's current operational status without disclosing specific financial results.

The interview was formally communicated to the stock exchanges via a regulatory filing signed by Company Secretary Milind Wagh. The discussion focused on broad strategic and operational themes relevant to the specialty chemicals sector.

Interview details

The media interaction took place on the evening of September 29, 2026. The recording is accessible through the company's official website and the broadcast network's digital platforms.

The filing confirms that the interview content is available for public viewing, ensuring transparency in investor communications regarding the company's recent developments.

Vinati Organics has maintained its financial outlook for FY27, anticipating that performance will match FY26 levels before improving in FY28. The company projects 15% volume growth for the fiscal year.

Volume growth and product specific targets

The specialty chemicals manufacturer expects its overall volume growth to reach 15% in FY27. Within this broader forecast, demand for ATBS (2-Acrylamido-2-methylpropane sulfonic acid), a key product line, is projected to grow by 15-20%. This specific segment outlook aligns with earlier indications that demand for ATBS would pick up in December.

Subsidiary revenue potential

The company also provided an estimate for its subsidiary, Veeral Organics. Vinati Organics estimates that Veeral Organics can reach a revenue range between ₹500-550 crore. This figure highlights the potential contribution from subsidiary operations to the group's consolidated performance.

Currency impact on exports

Earlier guidance noted that the decline in the rupee was anticipated to provide a boost to revenue. A softer domestic currency typically benefits exporters by making their products more competitively priced in international markets. This currency factor remains relevant as the company navigates the projected volume increases in FY27.